{"id":"https://openalex.org/W2897587545","doi":"https://doi.org/10.1016/j.jalz.2018.06.1407","title":"P3\u2010051: CCR3 ANTAGONISM DRIVES NEUROINFLAMMATORY BENEFITS IN AGED MICE","display_name":"P3\u2010051: CCR3 ANTAGONISM DRIVES NEUROINFLAMMATORY BENEFITS IN AGED MICE","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2897587545","doi":"https://doi.org/10.1016/j.jalz.2018.06.1407","mag":"2897587545"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2018.06.1407","doi":"https://doi.org/10.1016/j.jalz.2018.06.1407","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.1407","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036558068","display_name":"Sanket V. Rege","orcid":"https://orcid.org/0000-0001-9145-1664","observed_orcids":["https://orcid.org/0000-0001-9145-1664"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sanket Rege","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046510177","display_name":"Hannah Hackbart","orcid":"https://orcid.org/0009-0005-9128-9026","observed_orcids":["https://orcid.org/0009-0005-9128-9026"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hannah Hackbart","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075620744","display_name":"Eva Czirr","orcid":"https://orcid.org/0000-0003-0247-0631","observed_orcids":["https://orcid.org/0000-0003-0247-0631"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eva Czirr","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037456393","display_name":"Steven P. Braithwaite","orcid":"https://orcid.org/0000-0003-0520-8823","observed_orcids":["https://orcid.org/0000-0003-0520-8823"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven P. Braithwaite","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021110313","display_name":"Sakura Minami","orcid":"https://orcid.org/0000-0001-8505-4486","observed_orcids":["https://orcid.org/0000-0001-8505-4486"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Sakura Minami","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036558068"],"corresponding_institution_ids":["https://openalex.org/I4405267265"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12415273,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"7S_Part_20","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14144","display_name":"Neurological Disease Mechanisms and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10608","display_name":"Neurogenesis and neuroplasticity mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2806","display_name":"Developmental Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccr3-antagonists","display_name":"CCR3 antagonists","score":0.9259999990463257},{"id":"https://openalex.org/keywords/eotaxin","display_name":"eotaxin","score":0.8769999742507935}],"concepts":[{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.9523712396621704},{"id":"https://openalex.org/C2779830541","wikidata":"https://www.wikidata.org/wiki/Q1622829","display_name":"Microglia","level":3,"score":0.6882010102272034},{"id":"https://openalex.org/C2776464000","wikidata":"https://www.wikidata.org/wiki/Q545787","display_name":"Dentate gyrus","level":3,"score":0.6573002338409424},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.5435211658477783},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5406164526939392},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.472316712141037},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4658879339694977},{"id":"https://openalex.org/C4746552","wikidata":"https://www.wikidata.org/wiki/Q1456827","display_name":"Neurogenesis","level":2,"score":0.4621729254722595},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39153748750686646},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3647766709327698},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3467220664024353},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34401935338974},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3107178807258606},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28885525465011597},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.24773123860359192},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.21801963448524475},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13660040497779846}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2018.06.1407","doi":"https://doi.org/10.1016/j.jalz.2018.06.1407","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.1407","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2897028869","https://openalex.org/W4327814638","https://openalex.org/W2551935034","https://openalex.org/W2992739463","https://openalex.org/W2981096310","https://openalex.org/W4403544223","https://openalex.org/W4413920644","https://openalex.org/W2809324846","https://openalex.org/W3125639391","https://openalex.org/W3044706355"],"abstract_inverted_index":{"Recent":[0],"research":[1],"into":[2],"the":[3,43,64,135,153,191,199,209,217,230],"proteomic":[4],"composition":[5],"of":[6,118,144,155,160,168,183,193],"plasma":[7,71],"has":[8,36,236],"identified":[9],"specific":[10],"circulating":[11,130],"factors":[12],"that":[13,35,79,173,228],"increase":[14,65],"with":[15,21,33,175,198,220,233],"age":[16],"and":[17,24,52,120,129,141,163,187,222],"are":[18],"directly":[19],"associated":[20,219,241],"cognitive":[22,87],"decline":[23],"neurodegeneration.":[25],"CCL11":[26,67,80,211],"(eotaxin)":[27],"is":[28,77],"one":[29],"such":[30],"factor":[31],"elevated":[32],"aging":[34,221],"been":[37],"shown":[38],"to":[39,56,101,109,151,239],"reduce":[40],"neurogenesis":[41],"in":[42,66,70,84,89,134,147,158,180,190,208,216],"dentate":[44],"gyrus":[45],"as":[46,48],"well":[47],"impair":[49],"hippocampal":[50],"learning":[51],"memory":[53],"when":[54],"administered":[55,100],"young":[57,148],"mice":[58,105,150],"(Villeda,":[59],"et":[60],"al.":[61],"2011).":[62],"Given":[63],"levels":[68,182],"observed":[69],"from":[72,127],"Alzheimer's":[73],"disease":[74,242],"patients,":[75],"it":[76],"possible":[78],"plays":[81,212],"a":[82,176,213],"role":[83,215],"mechanisms":[85],"underlying":[86],"function":[88],"neurodegenerative":[90,223],"disease,":[91],"including":[92],"neuroinflammation.":[93,115],"A":[94],"CCR3":[95,156,177,231],"(CCL11":[96],"receptor)":[97],"antagonist":[98,178,200,235],"was":[99,122],"23-month-old":[102],"aged":[103,194],"C57Bl/6":[104,149],"for":[106],"3":[107],"weeks":[108],"measure":[110],"its":[111],"effect":[112],"on":[113,124],"age-dependent":[114],"Immunohistochemical":[116],"assessment":[117,167],"astrocytes":[119],"microglia":[121,207],"performed":[123,165],"brain":[125],"tissues":[126],"mice,":[128],"cytokines":[131,186],"were":[132],"measured":[133],"plasma.":[136],"We":[137,171],"then":[138],"used":[139],"acute":[140],"chronic":[142],"models":[143,159],"LPS":[145],"administration":[146],"determine":[152],"effects":[154],"inhibition":[157],"induced":[161],"neuroinflammation,":[162,203],"again":[164],"immunohistochemical":[166],"neuroinflammatory":[169],"markers.":[170],"demonstrate":[172,227],"treatment":[174,197],"resulted":[179],"reduced":[181],"systemic":[184],"inflammatory":[185],"decreased":[188],"neuroinflammation":[189,218],"hippocampus":[192],"mice.":[195],"Additionally,":[196],"diminished":[201],"LPS-induced":[202],"significantly":[204],"reducing":[205],"activated":[206],"hippocampus.":[210],"significant":[214],"disease.":[224],"Our":[225],"findings":[226],"targeting":[229],"receptor":[232],"an":[234],"therapeutic":[237],"potential":[238],"alleviate":[240],"phenotypes.":[243]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-10-26T00:00:00"}
